FDAnews
www.fdanews.com/articles/97495-elan-biogen-idec-say-tysabri-recommended-by-nice-for-ms-treatment

Elan, Biogen Idec Say Tysabri Recommended by NICE for MS Treatment

August 22, 2007

The UK’s National Institute for health and Clinical Excellence, NICE, has recommended the use of Tysabri for the treatment of relapsing multiple sclerosis.
ABC Money.co.uk